# RUM Group Inc.: financial statements, quarterly

RUM · Nasdaq · CIK 1830081 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rum.md) · [Financials](/companies/rum/financials.md) · [Filings](/companies/rum/filings.md) · [Insiders](/companies/rum/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rum/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [18.0](/filings/0001213900-24-096789.md) | [20.4 d](/filings/0001013762-25-001863.md) | [17.7](/filings/0001213900-25-041074.md) | [22.5](/filings/0001213900-25-073910.md) | [25.1](/filings/0001213900-25-108230.md) | [30.2 d](/filings/0001213900-26-024099.md) | [23.7](/filings/0001213900-26-056616.md) | [1.0](/filings/0001213900-25-073910.md) | [24.8](/filings/0001213900-25-108230.md) | [27.1 d](/filings/0001213900-26-024099.md) | [25.5](/filings/0001213900-26-056616.md) | [40.4](/filings/0001213900-26-087311.md) |
| Cost of revenue | $m | [39.8](/filings/0001213900-24-096789.md) | [39.5 d](/filings/0001013762-25-001863.md) | [31.8](/filings/0001213900-25-041074.md) | [35.7](/filings/0001213900-25-073910.md) | [36.4](/filings/0001213900-25-108230.md) | [34.5 d](/filings/0001213900-26-024099.md) | [30.0](/filings/0001213900-26-056616.md) | [5.5](/filings/0001213900-26-087311.md) | [25.2](/filings/0001213900-25-108230.md) | [25.6 d](/filings/0001213900-26-024099.md) | [27.0](/filings/0001213900-26-056616.md) | [7.4](/filings/0001213900-26-087311.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [5.1](/filings/0001213900-24-096789.md) | [3.6 d](/filings/0001013762-25-001863.md) | [4.5](/filings/0001213900-25-041074.md) | [5.3](/filings/0001213900-25-073910.md) | [4.7](/filings/0001213900-25-108230.md) | [4.4 d](/filings/0001213900-26-024099.md) | [4.8](/filings/0001213900-26-056616.md) | [4.8](/filings/0001213900-26-087311.md) | [4.5](/filings/0001213900-25-108230.md) | [4.7 d](/filings/0001213900-26-024099.md) | [5.7](/filings/0001213900-26-056616.md) | [6.8](/filings/0001213900-26-087311.md) |
| Operating income | $m | [(40.2)](/filings/0001213900-24-096789.md) | [(37.2) d](/filings/0001013762-25-001863.md) | [(35.0)](/filings/0001213900-25-041074.md) | [(38.8)](/filings/0001213900-25-073910.md) | [(32.8)](/filings/0001213900-25-108230.md) | [(24.2) d](/filings/0001213900-26-024099.md) | [(36.4)](/filings/0001213900-26-056616.md) | [(26.6)](/filings/0001213900-26-087311.md) | [(28.1)](/filings/0001213900-25-108230.md) | [(35.5) d](/filings/0001213900-26-024099.md) | [(39.1)](/filings/0001213900-26-056616.md) | [(70.8)](/filings/0001213900-26-087311.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001213900-24-096789.md) | [(3.3) d](/filings/0001013762-25-001863.md) | [(0.0)](/filings/0001213900-25-041074.md) | [0.2](/filings/0001213900-25-073910.md) | [(0.1)](/filings/0001213900-25-108230.md) | [(2.1) d](/filings/0001213900-26-024099.md) | [0.0](/filings/0001213900-26-056616.md) | [0.0 d](/filings/0001213900-26-087311.md) | [0.0 d](/filings/0001213900-25-108230.md) | [0.0 d](/filings/0001213900-26-024099.md) | [0.0](/filings/0001213900-26-056616.md) | [0.2](/filings/0001213900-26-087311.md) |
| Net income | $m | [(29.0)](/filings/0001213900-24-096789.md) | [(29.3) d](/filings/0001013762-25-001863.md) | [(43.3)](/filings/0001213900-25-041074.md) | [(26.8)](/filings/0001213900-25-073910.md) | [(31.5)](/filings/0001213900-25-108230.md) | [(237) d](/filings/0001213900-26-024099.md) | [(2.7)](/filings/0001213900-26-056616.md) | [(30.2)](/filings/0001213900-26-087311.md) | [(16.3)](/filings/0001213900-25-108230.md) | [(32.7) d](/filings/0001213900-26-024099.md) | [(30.3)](/filings/0001213900-26-056616.md) | [(79.1)](/filings/0001213900-26-087311.md) |
| Diluted EPS | $ per share | [(0.14)](/filings/0001213900-24-096789.md) | not reported | [(0.21)](/filings/0001213900-25-041074.md) | [(0.13)](/filings/0001213900-25-073910.md) | [(0.15)](/filings/0001213900-25-108230.md) | not reported | [(0.01)](/filings/0001213900-26-056616.md) | [(0.12)](/filings/0001213900-26-087311.md) | [(0.06)](/filings/0001213900-25-108230.md) | not reported | [(0.12)](/filings/0001213900-26-056616.md) | [(0.28)](/filings/0001213900-26-087311.md) |
| Basic EPS | $ per share | [(0.14)](/filings/0001213900-24-096789.md) | not reported | [(0.21)](/filings/0001213900-25-041074.md) | [(0.13)](/filings/0001213900-25-073910.md) | [(0.15)](/filings/0001213900-25-108230.md) | not reported | [(0.01)](/filings/0001213900-26-056616.md) | [(0.12)](/filings/0001213900-26-087311.md) | [(0.06)](/filings/0001213900-25-108230.md) | not reported | [(0.12)](/filings/0001213900-26-056616.md) | [(0.28)](/filings/0001213900-26-087311.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [266](/filings/0001213900-23-086112.md) | [218](/filings/0001013762-25-001863.md) | [183](/filings/0001213900-24-042939.md) | [153](/filings/0001213900-24-067682.md) | [131](/filings/0001213900-24-096789.md) | [114](/filings/0001213900-26-024099.md) | [301](/filings/0001213900-25-041074.md) | [284](/filings/0001213900-25-073910.md) | [270](/filings/0001213900-25-108230.md) | [238](/filings/0001213900-26-087311.md) | [219](/filings/0001213900-26-056616.md) | [203](/filings/0001213900-26-087311.md) |
| Current assets | $m | [286](/filings/0001213900-23-086112.md) | [238](/filings/0001013762-25-001863.md) | [205](/filings/0001213900-24-042939.md) | [183](/filings/0001213900-24-067682.md) | [159](/filings/0001213900-24-096789.md) | [136](/filings/0001213900-26-024099.md) | [317](/filings/0001213900-25-041074.md) | [301](/filings/0001213900-25-073910.md) | [287](/filings/0001213900-25-108230.md) | [265](/filings/0001213900-26-087311.md) | [243](/filings/0001213900-26-056616.md) | [417](/filings/0001213900-26-087311.md) |
| Total assets | $m | [331](/filings/0001213900-23-086112.md) | [296](/filings/0001013762-25-001863.md) | [263](/filings/0001213900-24-042939.md) | [243](/filings/0001213900-24-067682.md) | [217](/filings/0001213900-24-096789.md) | [195](/filings/0001213900-26-024099.md) | [391](/filings/0001213900-25-041074.md) | [380](/filings/0001213900-25-073910.md) | [367](/filings/0001213900-25-108230.md) | [337](/filings/0001213900-26-087311.md) | [311](/filings/0001213900-26-056616.md) | [2,124](/filings/0001213900-26-087311.md) |
| Current liabilities | $m | [44.3](/filings/0001213900-23-086112.md) | [33.6](/filings/0001013762-25-001863.md) | [30.4](/filings/0001213900-24-042939.md) | [40.2](/filings/0001213900-24-067682.md) | [40.3](/filings/0001213900-24-096789.md) | [217](/filings/0001213900-26-024099.md) | [32.0](/filings/0001213900-25-041074.md) | [39.1](/filings/0001213900-25-073910.md) | [47.5](/filings/0001213900-25-108230.md) | [45.3](/filings/0001213900-26-087311.md) | [51.7](/filings/0001213900-26-056616.md) | [197](/filings/0001213900-26-087311.md) |
| Total liabilities | $m | [56.3](/filings/0001213900-23-086112.md) | [44.1](/filings/0001013762-25-001863.md) | [52.3](/filings/0001213900-24-042939.md) | [50.5](/filings/0001213900-24-067682.md) | [51.0](/filings/0001213900-24-096789.md) | [258](/filings/0001213900-26-024099.md) | [51.5](/filings/0001213900-25-041074.md) | [65.7](/filings/0001213900-25-073910.md) | [64.9](/filings/0001213900-25-108230.md) | [62.0](/filings/0001213900-26-087311.md) | [61.3](/filings/0001213900-26-056616.md) | [698](/filings/0001213900-26-087311.md) |
| Shareholders' equity | $m | [275](/filings/0001213900-24-096789.md) | [252](/filings/0001213900-26-024099.md) | [211](/filings/0001213900-25-073910.md) | [193](/filings/0001213900-25-108230.md) | [166](/filings/0001213900-25-108230.md) | [(63.1)](/filings/0001213900-26-056616.md) | [340](/filings/0001213900-26-056616.md) | [314](/filings/0001213900-25-108230.md) | [302](/filings/0001213900-25-108230.md) | [275](/filings/0001213900-26-056616.md) | [250](/filings/0001213900-26-056616.md) | [1,426](/filings/0001213900-26-087311.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(25.3) d](/filings/0001213900-24-096789.md) | [(33.1) d](/filings/0001013762-25-001863.md) | [(33.9)](/filings/0001213900-25-041074.md) | [(21.7) d](/filings/0001213900-25-073910.md) | [(19.1) d](/filings/0001213900-25-108230.md) | [(12.4) d](/filings/0001213900-26-024099.md) | [(14.5)](/filings/0001213900-26-056616.md) | [(15.9) d](/filings/0001213900-26-087311.md) | [(10.6) d](/filings/0001213900-25-108230.md) | [(29.4) d](/filings/0001213900-26-024099.md) | [(16.6)](/filings/0001213900-26-056616.md) | [(49.5) d](/filings/0001213900-26-087311.md) |
| Capital expenditure | $m | [3.3 d](/filings/0001213900-24-096789.md) | [3.6 d](/filings/0001013762-25-001863.md) | [0.4](/filings/0001213900-25-041074.md) | [1.4 d](/filings/0001213900-25-073910.md) | [0.9 d](/filings/0001213900-25-108230.md) | [0.0 d](/filings/0001213900-26-024099.md) | [0.1](/filings/0001213900-26-056616.md) | [0.2 d](/filings/0001213900-26-087311.md) | [1.4 d](/filings/0001213900-25-108230.md) | [2.3 d](/filings/0001213900-26-024099.md) | [1.1](/filings/0001213900-26-056616.md) | [42.1 d](/filings/0001213900-26-087311.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [525](/filings/0001213900-26-056616.md) | [0.0 d](/filings/0001213900-26-087311.md) | [0.0 d](/filings/0001213900-25-108230.md) | [0.0 d](/filings/0001213900-26-024099.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [178](/filings/0001213900-23-086112.md) | [203](/filings/0001213900-24-042939.md) | [201](/filings/0001213900-24-067682.md) | [202](/filings/0001213900-24-096789.md) | [202](/filings/0001213900-25-041074.md) | [204](/filings/0001213900-25-073910.md) | [205](/filings/0001213900-25-108230.md) | [237](/filings/0001213900-26-056616.md) | [260](/filings/0001213900-26-087311.md) | [261](/filings/0001213900-25-108230.md) | [261](/filings/0001213900-26-056616.md) | [284](/filings/0001213900-26-087311.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.